Table 3.
Atorvastatin 80 mg (n=24) | Atorvastatin 20 mg (n=23) | P | |||||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
Baseline | Week 6 | Week 12 | Baseline | Week 6 | Week 12 | Time | Dosage | Interactions | |
Tp53 | 0.27±0.05 | 0.25±0.03 | 0.35±0.06 | 0.20±0.05 | 0.17±0.03 | 0.21±0.06 | 0.358 | 0.015 | 0.707 |
ATF4 | 0.82±0.04 | 0.84±0.04 | 0.74±0.03 | 0.80±0.04 | 0.85±0.04 | 0.78±0.03 | 0.038 | 0.737 | 0.643 |
CHOP | 0.60±0.05 | 0.84±0.17 | 0.62±0.11 | 0.53±0.05 | 0.60±0.16 | 0.65±0.11 | 0.350 | 0.374 | 0.451 |
C/EBP | 0.80±0.04 | 0.72±0.03 | 0.63±0.04 | 0.79±0.03 | 0.77±0.03 | 0.73±0.04 | 0.003 | 0.088 | 0.244 |
TRIB3 | 0.80±0.05 | 0.74±0.05 | 0.86±0.08 | 0.72±0.05 | 0.70±0.05 | 0.74±0.08 | 0.358 | 0.045 | 0.717 |
Notes: Data are means ± SEM. Abbreviations: Tp53, tumor protein 53; ATF4, activating transcription factor 4; C/EBP, CCAAT/enhancer binding protein; CHOP, C/EBP homologous protein; TRIB3, Tribbles 3.